UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$158.41K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 14, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$499.73
Aug 14, 2026
Close before public filing
$499.73
Aug 14, 2026
Return since public filing
-0.52%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 320 shares @ $495.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000121
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.03M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $1.81M |
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $160.8K |
| United Therapeutics Corp UTHR | Exercise | Aug 14, 2026 | $1.29M |
| United Therapeutics Corp UTHR Current | Sale | Aug 14, 2026 | $158.41K |
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $205.33K |
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $267.01K |
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $1.06M |
| United Therapeutics Corp UTHR | Sale | Aug 14, 2026 | $1.07M |
| United Therapeutics Corp UTHR | Exercise | Aug 14, 2026 | $0 |